Cancer Scientists at the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch and the Charit Universitts Medizin Berlin (Gera number of) have identified a gene which enables them to predict for the first time with high probability if colon cancer is going to metastasize. Assistant Professor Dr. Ulrike Stein, Professor Peter M. Schlag, and Professor Wa […]
Scientists at the Mayo Clinic campus in Florida have observed that a drug now being tested to treat a range of human cancers significantly inhibited colon cancer development in mice. Because the agent appears to have minimal side effects, it may represent an effective chemopreventive therapy in people at high risk for colon cancer, the researchers say....... […]
Computed tomographic colonography (CTC), also known as virtual colonoscopy, remains effective in screening older patients for colorectal cancer (CRC), produces low referral for colonoscopy rates similar to other screening exams now covered by Medicare, and does not result in unreasonable levels of additional testing resulting from extracolonic findings, as p […]
(PHILADELPHIA) Findings reported in the Journal of the American Medical Association by scientists at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer. Detection of the biomarker, guanylyl cyclase 2C (GUCY2C), indicates the presence of […]
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, as per research from The University of Texas M. D. Anderson Cancer Center. The findings appear in the Dec. 2 issue of JAMA....... […]